Navigation Links
Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug

TSX-V: PGA

VANCOUVER, May 07, 2007 /PRNewswire-FirstCall/ - Pacgen Biopharmaceuticals Corporation ("Pacgen") is pleased to report that topline results from its Phase I/II study of PAC-113, a novel antifungal, show it is generally safe, well-tolerated, and active in the treatment of oral Candida infection with clinical cure rates comparable to the current standard of care. Based on these results the Company plans to initiate a Phase IIb study to optimize PAC-113 dose and formulation.

"For many immunocompromised patients oral candidiasis can be severe, impacting their ability to get appropriate nutrition. We are very encouraged by the PAC-113 results and its potential to help patients with oral candidiasis, particularly when available treatments have a number of limitations and drawbacks," said Dr. Neil Reiner, Professor and Head of Division of Infectious Diseases, UBC Department of Medicine and Vancouver General Hospital, and a member of Pacgen's Clinical Advisory Board

PAC-113 is a peptide based anti-fungal drug candidate targeting oral Candida infections in immunocompromised patients and patients with salivary dysfunction. The Phase I/II clinical trial of PAC-113 was conducted at sites in the United States and South Africa and recruited over 100 HIV seropositive patients with oral candidiasis.

The objective of this study was to provide safety data for PAC-113, as well as to establish first proof of efficacy for PAC-113 in eliminating clinical signs and symptoms of oral candidiasis. This Phase I/II study was a comparison between PAC-113 mouthrinse and Nystatin oral suspension. The study was a randomized, examiner-blinded, parallel design clinical trial that included a 14-day treatment phase, and a 14-day follow-up period, with a day 28 follow-up visit. Analyses were conducted on patients who were at least 80% compliant in the treatment phase.

Topline results show that 37% of PAC-113
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lmsnqn/medical_equipment ) ... Rental and Leasing - Global Strategic Business Report" ... the worldwide markets for Medical Equipment Rental and Leasing ... for the US, Japan , ... Annual estimates and forecasts are provided for the ...
(Date:4/17/2015)... , April 17, 2015  In Detroit, where three ... mortality rate is two and one half times of the ... 6 of 10 infants that die in Detroit ... sobering statistics that Covenant Community Care, a faith-based, charitable non-profit ... poised to change thanks to a charitable donation by Konica ...
(Date:4/17/2015)... DALLAS , Apr. 17, 2015 Steven ... ( ALGA ), and its operating subsidiary American Seed ... an exclusive presentation to investors yesterday in New York ... Strategy. The American Seed & Oil Company ... , Hippie Butter Hemp Seed Foods , the ...
Breaking Medicine Technology:Medical Equipment Rental and Leasing Market 2015-2020 - Global Strategic Business Report - Healthcare Spending Slowdown Bodes Well for Medical Equipment Leasing 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3
... Nov. 29, 2011 Hamamatsu Photonics introduces ... exceptional quantum efficiency and low noise, the ... cooled CCDs, and first-generation scientific CMOS cameras. ... Now one camera covers a wide range ...
... Ala., Nov. 28, 2011 Qualitest Pharmaceuticals today announced that ... (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.05 mg/0.03 mg, 0.075 ... The total sales for Myzilra Tablets in the ... approximately $34.4 million, according to IMS Health. ...
Cached Medicine Technology:Hamamatsu Introduces the ORCA-Flash4.0 Scientific CMOS Camera With High Sensitivity, High Resolution, and Fast Readout 2
(Date:4/18/2015)... Carinsurancequotesinfo.com has released a new blog post explaining ... caused by a car accident. , Car insurance ... A policy can pay for car repairs and even ... carry appropriate coverage when they are driving. ... several important riders that offer extra coverage options. One ...
(Date:4/18/2015)... "I recognized the need for a better ... an inventor from Cincinnati, Ohio. "This need inspired me ... the Slyde Door to offer an alternative to the ... provides convenient storage space for an evacuation stretcher. The ... patients. , This offers added peace of mind ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining how ... , Clients can review important auto insurance quotes online, ... important advantages for clients who need affordable financial security ... have coverage for their vehicles can purchase a policy ... Many agencies offer important discounts and drivers can learn ...
(Date:4/18/2015)... Patients who undergo radiation for a ... in life, but the disease is likely to differ ... to radiation. Surviving Mesothelioma has just posted the details ... here to read it now. , Scientists from ... 45 patients who had both a hematologic cancer (like ...
(Date:4/18/2015)... than 2000 styles of newly designed prom dresses are ... carrying celebrity inspired special occasion dresses. With the prom ... for their prom. For those who are still looking ... be an ideal choice. , "We have by ... the most loved styles seen at this years major ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2
... Five Cleveland ... in ,The Best Lawyers in America®, annual peer-review publication. , ... Cleveland, OH (PRWEB) September 16, 2009 -- The 2009 Edition ... & Liber Ohio Law Firm as among the nation,s top lawyers. ,The Best ...
... , ROCKVILLE, Md., Sept. 16 ... Allergy and Infectious Diseases (NIAID) of the National Institutes of Health ... (SBIR) Grant. The award for two years is $1.99 million. Subject ... will bring the total to nearly $3 million. This new funding ...
... , , NEW YORK, Sept. 15 ... Jewish groups in the United States who are concerned about ... woman plan to protest outside the hospital,s Manhattan office at 50 W. ... The woman,s child, now three and a half years of ...
... ... year. , ... September 15, 2009 -- InSound Medical , manufacturer and developer of Lyric®, the first ... "Tell Us Your Lyric Hearing Story" Contest. Lyric wearers have the opportunity to win ...
... , , ANN ... influenza attacked Mexico explosively in late April 2009, the world ... manage the emerging public health crisis. , , ... April 24, setting into motion a broad range of community ...
... , , ... innovative wellness programs, luxury specialist Crystal Cruises is introducing aboard ... Through an exclusive new partnership with LEKI USA, a leading ... to break new ground in fitness options at sea. ...
Cached Medicine News:Health News:Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 2Health News:Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 3Health News:Sanaria Inc. Receives Multi-Year U.S. NIH Phase II Small Business Innovation Research Grant to Enhance Efficiency and Scale-up of its Malaria Vaccine Manufacturing Process 2Health News:American Jews to Protest Against Hadassah Hospital 2Health News:InSound Medical Kicks Off "Tell Us Your Story" Contest 2Health News:Community Mitigation Lessons From Mexico's A(H1N1) Response 2Health News:Community Mitigation Lessons From Mexico's A(H1N1) Response 3Health News:New Nordic Poles Help Crystal Guests Explore New Terrain at Sea 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: